Joint project will accelerate the
constitution of relevant patient cohorts for clinical
research.
ROCKVILLE, MD - Mar 9, 2015 - Rockville, MD, USA - March
9th, 2015 - TEMIS, the
leading provider of Semantic Content Enrichment solutions for the
Enterprise, today announced that its solution Luxid® has been
chosen by Frances UNICANCER, the Federation of French Cancer
Centers (CLCCs), as the semantic module for its ConSoRe (Continuum
Soin-Recherche) project driven by SWORD Consulting and
Services.
Clinical Trials help progress the fight against cancer by
validating promising treatments on actual patients. The 20 French
CLCCs drive such clinical studies on coherent cohorts of patients
who have similar clinical profiles. But identifying patients whose
profile matches trial requirements is traditionally a particularly
laborious process involving the manual review of potentially
millions of patient records. This pre-screening step therefore
considerably slows down the launch of clinical studies.
The focus of the ConSoRe project is a search tool enabling
Cancer Centers to rapidly aggregate coherent cohorts of patients
who meet the required criteria (gender, tumor type, treatment …).
ConSoRe enables researchers to rapidly evaluate the
feasibility of their proposed clinical study. If a sufficient
number of candidates are identified, they are then contacted to
implement the study, explains Emmanuel Reyrat, Information
Systems Director at UNICANCER.
ConSoRe implements a data processing workflow that accelerates
this identification phase. At the core of this workflow automated
by Antidots AIF and AFS solutions, TEMISs Luxid® platform
extracts medical references, family histories, TNM cancers and
tumors classification as well as their locations, from patient
records. This information is then indexed as metadata and leveraged
in the form of facets to accelerate the search and navigation
process within patient records and ultimately the selection of
relevant candidates. ConSoRe is currently being tested in 4 pilot
CLCCs: Georges-François Leclerc Center in Dijon, Regional Institute
of Cancer of Montpellier, Curie Institute in Paris and Léon Bérard
Center in Lyon.
In ConSoRe, patient records are first normalized to a pivot
format and then semantically structured with the Luxid® platform
fromTEMIS, said Frederik Joly, Project Manager,
SWORD. We have been working in close collaboration with TEMIS
for several years on semantic projects and a genuine relationship
of trust has developed between our two companies.
The digital transformation comes with a 50% annual increase
of unstructured content. In healthcare, analytics applied to
« Textual Big Data » such as patient records is
instrumental both in focusing research, as well as in developing
personalized, more efficient and inexpensive treatments, said
Daniel Mayer, VP Product & Marketing, TEMIS. ConSoRe
further affirms Luxid®s positioning as a strategic accelerator in
healthcare.
* * *
About UNICANCER
UNICANCER brings together the 20 French Comprehensive Cancer
Centers (FCCC), promotes their cancer research organisation and
pools resources and competencies to give a new dynamic to patient
care. The French Comprehensive Cancer Centers have held a special
place in the French health care system. These private, non-profit
establishments are entirely devoted to fighting cancer with a view
to public service. They have a threefold mission: patient care,
research and teaching. The cancer care and research organisation
model of the FCCC has been built around multidisciplinary practice,
individualised treatment and a research-healthcare continuum.
UNICANCER in figures: 20 healthcare establishments, more than
110 000 patients hospitalized every year, 18 000 employees, 2
billion euros in total revenue.
Website:http://www.unicancer.fr/en
About TEMIS
TEMIS helps organizations structure, manage and exploit their
unstructured information assets. Its flagship platform, Luxid®,
identifies and extracts targeted information to semantically enrich
content with domain-specific metadata. This enables organizations
to intelligently archive, manage, package, deliver, access and
analyze their textual Big Data.
TEMIS innovative solutions have attracted the business of
leading scientific organizations such as AAAS (American Association
for the Advancement of Science), ASCB, BASF, Bayer Pharma,
Elsevier, INRA, Merck KGaA, RSNA, Sanofi, Springer Science+Business
Media, Thieme, Thomson Reuters Scientific, the U.S. Department of
Agriculture, Volkswagen, Wiley and Wolters Kluwer.
Founded in 2000, TEMIS operates in the United States, Canada,
UK, France and Germany, and is represented worldwide through its
network of certified partners.
Website:http://www.temis.com
Blog:tagline.temis.com
Follow us on Twitter: @TEMIS_Group
About SWORD Group
SWORD Group (NYSE Euronext: FR0004180578 SWP) delivers high
value business applications (IT Services & Software) to the
worlds largest companies globally. With operations in 50
countries, SWORD today employs over 1,200 people and generates
€117.1m in consolidated revenue.
An international leader in the delivery of Business Process
Improvement solutions and data optimization, SWORDs skills,
infrastructure and experience help our customers across regulated
industries optimize performance, increase efficiencies and maximize
return on investment. SWORD has developed expertise in several
niche technologies, and in particular in search solutions and
semantic data manipulation, through its partnership with TEMIS.
With flexible delivery options, including On Demand and On
Premises, combined with our extensive industry expertise, SWORD
provides comprehensive support to customers across insurance and
healthcare, energy, banking and finance, telecoms, utilities,
engineering and construction and the public sector.
Website:http://www.sword-group.com